In Vivo - Strategic Analysis For Medtech And Pharma Leaders since 1981
Podcasts
• By
Harness Therapeutics' CEO talked to In Vivo about the company's strategy for expansion and partnering in the neurodegeneration space.
Growth
Innovation
• By
Harness Therapeutics' CEO talked to In Vivo about the company's strategy for expansion and partnering in the neurodegeneration space.
• By
Gingko Bioworks has released a large language model designed to improve mRNA stability.
Leadership
Market Access
• By
Lawmaking in Germany came to a halt after the federal election was called, meaning cardiovascular detection and pharmacy legislation were put on hold. In part one of a two-part interview on key themes for industry, Martin Walger, chief executive of the IVDs industry association, the VDGH, lays out the hopes and fears of IVD companies in the run up to the late February vote.